Trials / Completed
CompletedNCT01101217
Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Shiraz University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to study the effect of zinc supplementation in end stage renal failure on hemocystein level.
Detailed description
hemocystein increased in end stage renal failure and zinc involved in hemocystein metabolism thus zinc supplementation may be effective on hemocystein level.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zinc Supplement | in 50 patients zinc sulfate 220 mg per day orally for 6 weeks |
| DRUG | placebo | placebo daily for 6 weeks |
Timeline
- Start date
- 2009-02-01
- Completion
- 2009-09-01
- First posted
- 2010-04-09
- Last updated
- 2010-04-09
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01101217. Inclusion in this directory is not an endorsement.